Literature DB >> 2369381

Differentiation of field isolates of Pasteurella multocida serotype 3,4 from live vaccine strain by genotypic characterization.

K P Snipes1, D C Hirsh, R W Kasten, T E Carpenter, D W Hird, R H McCapes.   

Abstract

Fifty-five serotype 3,4 isolates of Pasteurella multocida, isolated from turkeys dead from fowl cholera, were characterized (fingerprinted) genotypically for comparison with the serotype 3,4 live fowl cholera vaccine principally used in turkeys in California. Twenty-three isolates were obtained from turkeys vaccinated with the M9 live vaccine, and 32 additional isolates were from turkeys not vaccinated for fowl cholera. Methods of characterization included restriction endonuclease analysis of chromosomal DNA and ribotyping, a technique for highlighting restriction site heterogeneity of highly conserved ribosomal RNA genes and associated sequences using a radiolabeled rRNA probe. Eight different genotypes or ribotypes were detected in these isolates by the above methods. Of 23 isolates from M9-vaccinated turkeys flocks, 19 were the same ribotype as M9. Thirty of 32 isolates recovered from unvaccinated turkeys were different ribotypes from M9. The remaining two isolates resembled M9 and were recovered from two different flocks placed in succession on a turkey farm where a flock placed previously had been vaccinated with M9, suggesting interflock transmission. Ribotyping and restriction endonuclease analysis appear to be useful tools to aid in the determination of the role that the live vaccine plays in fowl cholera epidemiology.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2369381

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  8 in total

1.  Random amplified polymorphic DNA and amplified fragment length polymorphism analyses of Pasteurella multocida isolates from fatal fowl cholera infections.

Authors:  Brad S Huber; Darin V Allred; John C Carmen; David D Frame; David G Whiting; Jason R Cryan; Terry R Olson; Paul J Jackson; Karen Hill; Miriam T Laker; Richard A Robison
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  Role of outer membrane protein H (OmpH)- and OmpA-specific monoclonal antibodies from hybridoma tumors in protection of mice against Pasteurella multocida.

Authors:  M Vasfi Marandi; K R Mittal
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

3.  DNA fingerprinting of Pasteurella multocida recovered from avian sources.

Authors:  Alongkorn Amonsin; James F X Wellehan; Ling-Ling Li; Judy Laber; Vivek Kapur
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

4.  Comparison of DNA fingerprinting and serotyping for identification of avian Pasteurella multocida isolates.

Authors:  M A Wilson; M J Morgan; G E Barger
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

5.  Comparison of DNA fingerprints and somatic serotypes of serogroup B and E Pasteurella multocida isolates.

Authors:  M A Wilson; R B Rimler; L J Hoffman
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

6.  Identification of five outer membrane-associated proteins among cross-protective factor proteins of Pasteurella multocida.

Authors:  Louisa B Tabatabai; Emilie S Zehr
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

7.  Induction of protective immunity in rabbits by coadministration of inactivated Pasteurella multocida toxin and potassium thiocyanate extract.

Authors:  L Z Jarvinen; H Hogenesch; M A Suckow; T L Bowersock
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

8.  Pasteurella multocida produces a protein with homology to the P6 outer membrane protein of Haemophilus influenzae.

Authors:  R W Kasten; L M Hansen; J Hinojoza; D Bieber; W W Ruehl; D C Hirsh
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.